ESC 365 - Decreased device related thrombus and enhanced neo-endocardial tissue maturation with a new generation left atrial appendage closure (LAAC) device. An anticoagulation and antiplatelet free canin study

ESC Professional Premium Access

Decreased device related thrombus and enhanced neo-endocardial tissue maturation with a new generation left atrial appendage closure (LAAC) device. An anticoagulation and antiplatelet free canin study

Session: Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Topic: Left Atrial Appendage Closure

Speaker: Doctor W. Saliba (Cleveland, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Walid Saliba

Cleveland Clinic, Cleveland (United States of America)

0 follower

4 more presentations in this session

Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland

Speaker: Mrs S. Itainen-Stromberg (Helsinki, FI)

Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation

Speaker: Professor P. Kistler (Melbourne, AU)

Left atrial appendage occlusion versus standard of care in patients with atrial fibrillation and a prior thrombo-embolic event despite oral anticoagulant therapy: a propensity score matched comparison

Speaker: Professor L. Boersma (Nieuwegein, NL)

Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry

Speaker: Doctor W. Ding (Liverpool, GB)

Access the full session

Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Speakers: Doctor W. Saliba, Mrs S. Itainen-Stromberg, Professor P. Kistler, Professor L. Boersma, Doctor W. Ding

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources